NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events
Research Theme

Molecular Diagnostics

You are here: Home > News listings for Molecular Diagnostics

News for Molecular Diagnostics

Oxford wins government funding to evaluate prostate cancer detection system

16 June 2021 · Listed under Molecular Diagnostics, Multi-Modal Cancer Therapies, Technology and Digital Health

A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by the digital diagnostic company Paige, will be investigated in a multicentre clinical study led by the University of Oxford as part of a successful NHSX Artificial Intelligence Health and Care Award application. Paige Prostate automatically detects and highlights … Read more

Artificial intelligence tool for streamlining pathology workflow

26 May 2021 · Listed under Clinical Informatics and Big Data, Imaging, Molecular Diagnostics, Multi-Modal Cancer Therapies

A multidisciplinary team comprising University of Oxford academics and Oxford University Hospitals (OUH) pathologists has developed an algorithm that automates requests for additional investigation of diagnostically uncertain prostate biopsies. The team were supported by the NIHR Oxford BRC through its Molecular Diagnostics and Imaging themes. Nearly 50,000 cases of prostate cancer are diagnosed each year … Read more

Eight BRC projects get RCF funding

7 September 2020 · Listed under Cardiovascular, Clinical Informatics and Big Data, Diabetes and Metabolism, Gastroenterology and Mucosal Immunity, Genomic Medicine, Haematology and Stem Cells, Imaging, Molecular Diagnostics, Multi-Modal Cancer Therapies, Multimorbidity and Long-Term Conditions, Neurological Conditions, Stroke and Vascular Dementia, Surgical Innovation and Evaluation, Technology and Digital Health

Eight Oxford BRC proposals, many covering a number of themes, have been awarded NIHR Research Capability Funding (RCF) funding to take forward key areas of research. The selected projects that will be supported include: Developing a research centre devoted to urgent and acute care The creation of a state-of-the-art imaging centre; and of a new … Read more

Test developed to identify new-borns at risk of leukaemia

21 August 2020 · Listed under Haematology and Stem Cells, Molecular Diagnostics

Oxford researchers have developed a new method to quickly identify cancerous cells in babies at risk of leukaemia. The team hope that the new protocol could make rapid testing more accessible for clinical laboratories around the globe. Until now, the only reliable way to know if a baby with Down’s syndrome is at risk of … Read more

BRC researchers’ work recognised with Vice-Chancellor’s Awards

30 July 2020 · Listed under Molecular Diagnostics, Surgical Innovation and Evaluation, Vaccines for Emerging and Endemic Diseases

A number of Oxford BRC-supported researchers have been recognised in this year’s University of Oxford Vice-Chancellor Innovation Awards. The Vice-Chancellor Innovation Awards celebrate research-led innovation that is having societal or economic impact. Prof Robert MacLaren, who leads the BRC’s Surgical Innovation theme, was named winner of the Inspiring Leadership category for his work on creation and spin-out of … Read more

Home colorectal cancer tests could prioritise patients for referral

20 July 2020 · Listed under Molecular Diagnostics, Multi-Modal Cancer Therapies

Non-invasive home-based tests that detect blood in patient stool samples offer an accurate and appropriate triaging method for GPs, according to University of Oxford researchers. The study, which is already informing a redesign of the colorectal cancer pathway at Oxford University Hospitals (OUH) NHS Foundation Trust, could prompt primary care services nationally to reprioritise symptomatic … Read more

Molecular Diagnostics theme hosts cancer genomics and immunology seminar

28 February 2020 · Listed under Molecular Diagnostics

The Molecular Diagnostics theme hosted a very successful seminar, ‘Advanced personalised therapies in gynaecological cancers’, at St Hugh’s College in February 2020. The meeting covered the genomics and immunology of cancer along with the emerging topic of advanced therapeutic medicinal products (ATMPs) in this setting. Speakers included Peter Cambell (Wellcome Sanger Institute) with a keynote … Read more

Study discovers genetic changes linked to leukaemia in children with Down’s syndrome

11 July 2019 · Listed under Haematology and Stem Cells, Molecular Diagnostics

Researchers at the University of Oxford have discovered the specific gene mutations that are required for the development of leukaemia in children with Down’s syndrome. Children with Down’s syndrome have a 150-fold increased risk of myeloid leukaemia, and while some of the genetic causes of this have been previously established, this is the first study … Read more

Summary of the Crohn’s & Colitis Open Evening

23 April 2019 · Listed under Molecular Diagnostics

Crohn's and Colitis Open Evening

On Thursday 7th February 2019, over 170 members of the public affected by Crohn’s Disease or Ulcerative Colitis attended a ‘Crohn’s and Colitis Open Evening’ at the John Radcliffe Hospital, Oxford. Below is a PDF summary of the event plus a slideshow with slides from the Powerpoint presentation given at the Open Evening.

Oxford researchers develop new technique to analyse cancer cells’ life history

11 February 2019 · Listed under Haematology and Stem Cells, Molecular Diagnostics

A team of researchers from the University of Oxford has developed a new technique that allows scientists to reliably track genetic errors in individual cancer cells, and find out how these might lead to uncontrollable growth. The research by the MRC Weatherall Institute of Molecular Medicine, supported by the NIHR Oxford Biomedical Research Centre, could … Read more

MDS Patient Support Group learn more about treatment of condition

13 October 2017 · Listed under Haematology and Stem Cells, Molecular Diagnostics

Patients and relatives affected by Myelodysplastic Syndromes (MDS) have visited the MRC Weatherall Institute of Molecular Medicine (WIMM) at the John Radcliffe Hospital to find out more about advances in treating the condition. The members of the Oxford and Thames Valley MDS Patient Support Group visited the WIMM Friday 29 September. MDS are a group … Read more

Molecular Diagnostics Theme

  • Introduction
  • Sub-theme 1: Cancer Genomics for Patient Benefit
  • Sub-theme 2: Predicting Disease Progression
  • Sub-theme 3: Precision Biomarkers
  • Sub-theme 4: Experimental Pathology
  • Cross-cutting role
  • Public engagement with Molecular Diagnostics
  • Contacts
  • Videos for this theme
  • News for this theme
  • General News Listings

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre